| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Mai―21 |
Ursane hybrids with 5-amino-1,2,3,4-thiatriazole, 1-tetrazole-5-thione, and 1-tetrazole-5-amines and study of their inhibition of main SARS-CoV-2 protease |
Sergey A. Popov, Elvira E. Shults, Dmitry S. Baev, Varvara Yu. Chirkova, Ekaterina A. Volosnikova, Svetlana V. Belenkaya, et al. (+4) Dmitry N. Shcherbakov, Mikhail.A. Pokrovsky, Mohammad S. Hamad, Andrey G. Pokrovsky |
| 2 |
[GO] |
2025―Apr―11 |
Evaluation of the diagnostic value of G protein-coupled estrogen receptor (GPER) in COVID-19 cases at Tokat Province |
Figen Guzelgul, Ergul Belge Kurutas |
| 3 |
[GO] |
2024―Okt―17 |
Invalidating betulinic acid as a potential inhibitor against the main protease of SARS-CoV-2 via combined approaches |
Jiankai Ye, Tao Xu, Rui Zhang, Xiaoping Liu, Chao Zhang, Yunyu Chen |
| 4 |
[GO] |
2024―Jan―03 |
Impact of anabolic androgenic steroids on COVID-19 |
Khaja Moinuddin shaik, Vijay Patibandla, Sukhendu Nandi |
| 5 |
[GO] |
2023―Dez―13 |
Design, synthesis and biological evaluation of betulinic acid derivatives as potential inhibitors of 3CL-protease of SARS-CoV-2 |
Yaowen Liu, Tianqing Nie, Jinjun Hou, Huali Long, Zijia Zhang, Min Lei, et al. (+2) Yechun Xu, Wanying Wu |
| 6 |
[GO] |
2023―Dez―02 |
Molecular mechanisms of dexamethasone actions in COVID-19: Ion channels and airway surface liquid dynamics |
Brian J. Harvey |
| 7 |
[GO] |
2022―Okt―05 |
Reaction of 7α-bromo-6-nitrocholest-5-enes with hydrazine: Formation of Steroidal pyrazolines and molecular docking against SARS-CoV-2 omicron protease |
Avadhesh Kumar, Mehtab Parveen, Mahboob Alam |
| 8 |
[GO] |
2022―Aug―24 |
Corticosteroids: A Boon or Bane for COVID-19 Patients? |
Subhadeep Sen, Bhagat Singh, Goutam Biswas |
| 9 |
[GO] |
2022―Mrz―26 |
The roles of methylprednisolone treatment in patients with COVID-19: a systematic review and meta-analysis |
Shukun Hong, Hongye Wang, Zhaolong Zhang, Lujun Qiao |
